Janney Montgomery Scott LLC Sarepta Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

$35.8 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$113.33 - $163.85 $157,302 - $227,423	1,388 New	1,388 $219,000
Q3 2023 Nov 08, 2023	BUY	$102.5 - $123.59 $2.11 Million - $2.54 Million	20,566 Added 1019.13%	22,584 $2.74 Million
Q2 2023 Jul 26, 2023	SELL	$106.4 - $157.19 $19,471 - $28,765	-183 Reduced 8.31%	2,018 $231,000
Q1 2023 Apr 28, 2023	SELL	$117.53 - $155.99 $181,936 - $241,472	-1,548 Reduced 41.29%	2,201 $303,000
Q4 2022 Feb 01, 2023	BUY	$100.86 - $132.13 $378,124 - $495,355	3,749 New	3,749 $486,000
Q2 2022 Aug 03, 2022	SELL	$62.69 - $88.44 $203,930 - $287,695	-3,253 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$63.15 - $90.42 $10,167 - $14,557	-161 Reduced 4.72%	3,253 $254,000
Q4 2021 Jan 27, 2022	BUY	$77.28 - $99.42 $49,304 - $63,429	638 Added 22.98%	3,414 $307,000
Q3 2021 Oct 29, 2021	SELL	$65.97 - $92.48 $102,781 - $144,083	-1,558 Reduced 35.95%	2,776 $257,000
Q2 2021 Jul 26, 2021	BUY	$69.38 - $86.75 $26,364 - $32,965	380 Added 9.61%	4,334 $337,000
Q1 2021 Apr 27, 2021	SELL	$72.25 - $168.95 $36,919 - $86,333	-511 Reduced 11.44%	3,954 $295,000
Q4 2020 Jan 25, 2021	SELL	$125.56 - $178.74 $41,811 - $59,520	-333 Reduced 6.94%	4,465 $761,000
Q3 2020 Nov 06, 2020	SELL	$127.12 - $172.34 $20,720 - $28,091	-163 Reduced 3.29%	4,798 $674,000
Q2 2020 Jul 23, 2020	BUY	$93.0 - $171.7 $10,881 - $20,088	117 Added 2.42%	4,961 $795,000
Q1 2020 Apr 30, 2020	SELL	$82.38 - $131.64 $38,553 - $61,607	-468 Reduced 8.81%	4,844 $474,000
Q4 2019 Jan 21, 2020	BUY	$76.53 - $135.58 $29,234 - $51,791	382 Added 7.75%	5,312 $685,000
Q3 2019 Oct 29, 2019	BUY	$72.81 - $156.91 $62,034 - $133,687	852 Added 20.89%	4,930 $371,000
Q2 2019 Jul 29, 2019	BUY	$112.21 - $151.95 $12,230 - $16,562	109 Added 2.75%	4,078 $620,000
Q1 2019 Apr 30, 2019	BUY	$106.67 - $151.68 $138,884 - $197,487	1,302 Added 48.82%	3,969 $473,000
Q4 2018 Feb 01, 2019	SELL	$97.32 - $148.76 $39,901 - $60,991	-410 Reduced 13.32%	2,667 $291,000
Q3 2018 Nov 05, 2018	BUY	$115.31 - $161.51 $25,944 - $36,339	225 Added 7.89%	3,077 $497,000
Q2 2018 Jul 24, 2018	SELL	$71.74 - $153.69 $291,838 - $625,210	-4,068 Reduced 58.79%	2,852 $377,000
Q1 2018 Apr 19, 2018	SELL	$54.02 - $82.27 $517,889 - $788,722	-9,587 Reduced 58.08%	6,920 $513,000
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $288,793 - $344,018	6,062 Added 58.04%	16,507 $918,000
Q3 2017 Nov 15, 2017	BUY	$35.73 - $47.15 $373,199 - $492,481	10,445	10,445 $474,000

Others Institutions Holding SRPT

# of Institutions

548

Shares Held

85.8M

Call Options Held

3.64M

Put Options Held

1.68M

Black Rock Inc. New York, NY

10.3M
Shares

$1.26 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

9.04M
Shares

$1.1 Billion
0.03% of portfolio
Capital International Investors Los Angeles, CA

4.32M
Shares

$525 Million
0.14% of portfolio
State Street Corp Boston, MA

4.14M
Shares

$504 Million
0.03% of portfolio
Janus Henderson Group PLC London, X0

3.82M
Shares

$464 Million
0.33% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.6B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account